Cost-effectiveness analysis of different hypertension management strategies

Despite the availability of a large number of effective and relatively safe antihypertensive drugs, the control of hypertension in general population is suboptimal, reaching the 70% in the best practice settings. In particular, despite its economic power, Europe also ranges among the regions with the lowest rates of hypertension awareness and control worldwide [1]. On the one hand, this predominance reflects the increasing life expectancy in European population, whereas on the other hand, it can be attributed to the sedentary lifestyle and the nutritional habits of wealthy societies, but also to medical inertia, insufficient patient education and contradictory recommendations from different institutions and scientific societies [2]. In this context, the comparative evaluation of the effectiveness of different tools to improve hypertension control is of great interest, especially if the cost of the intervention is also estimated.